Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-07 · accession 0001567619-23-004744 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-09 | 2023-03-07 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -260 | 487 | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-07 | G | D | 260 | $0.00 | 487 | I See footnote | — | — | (F1) The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee. |